Archive: 10/04/2013
Engineered antibody demonstrated safety, efficacy in wide range of advanced tumors
(Medical Xpress)—The engineered antibody MPDL3280A, which targets a protein called programmed death-ligand 1 (PD-L1), was safe and effective for several cancers, according to phase I study results presented at the AACR ...
Apr 10, 2013
New approach evaluates effect of physical activity on estrogen metabolism in postmenopausal women
Researchers have generated new insights into the ways in which physical activity affects how much estrogen is broken down and secreted in the urine of postmenopausal women. These findings enhance understanding of the potential ...
Apr 10, 2013
New study exposes link between pesticides and childhood brain tumours
A new study from the Telethon Institute for Child Health Research has revealed a potential link between professional pesticide treatments in the home and a higher risk of children developing brain tumours.
Apr 10, 2013